West Syndrome Market Size

  • Report ID: 4397
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

West Syndrome Market Size

West Syndrome Market size was valued at USD 1.11 billion in 2024 and is likely to cross USD 2.17 billion by 2037, registering more than 5.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of west syndrome is estimated at USD 1.21 billion.

The growth of the market can be attributed to the rising prevalence of epilepsy. The World Health Organization (WHO) provided a report stating that nearly 5 million individuals are diagnosed with epilepsy every year worldwide. Epilepsy is one of the most common chronic disorders across the world. It is a non-communicable disease that affects the central nervous system and causes physical impairment of the body. The recurrent seizures cause discomfort in movement eventually leading to paralysis. It is mainly caused by brain damage, head injury, absence of oxygen, brain infection, brain tumor, meningitis, encephalitis, and neurocysticercosis.

Global west syndrome market trends such as growing awareness of west syndrome in the global population and rising healthcare expenditure are projected to influence the growth of the market positively over the forecast period. In a report published by the World Bank, it was stated that in 2019, the healthcare expenditure reached 1,121.9 per capita. West syndrome is a serious medical condition with a drastically irregular pattern of brain waves which is also known as hypsarrhythmia. West syndrome also includes features such as infantile spasms and loss of developmental milestones. Moreover, spiking R&D spending on neurological illnesses and the rising inclination of the global population toward novel therapies are further anticipated to propel the growth of the market over the forecast period.


Flexible-Plastic-Packaging-Coating-Market-scope.jpg
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4397
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of west syndrome is estimated at USD 1.21 billion.

The west syndrome market size was valued at USD 1.11 billion in 2024 and is likely to cross USD 2.17 billion by 2037, registering more than 5.3% CAGR during the forecast period i.e., between 2025-2037. Higher prevalence of drug seizures and significant growth in imaging technology will boost the market growth.

North America industry is set to hold largest revenue share by 2037, attributed to escalation in the number of people living with traumatic brain injuries.

The major players in the market are Marinus Pharmaceuticals, Inc., SK Biopharmaceuticals Co., Ltd., Alkem Laboratories Ltd., Supernus Pharmaceuticals, Inc., Eisai Co., Ltd., Abbott Laboratories, Upsher-Smith Laboratories, LLC., Pfizer Inc., H. Lundbeck A/S, UCB S.A.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample